Real-World Efficacy of Atezolizumab in Patients with Previously Treated Advanced NSCLC in Spain - TRACKER Study

被引：0
|
作者：
Alvarez, R. [1 ]
Carcereny, E. [2 ,3 ]
Padilla, A. [4 ]
Rodriguez Garcia, J. M. [5 ]
Cordoba, J. F. [6 ]
Esteban, E. [7 ]
Aguado, C. [8 ]
Garde, J. [9 ]
Moreno Vega, A. [10 ]
Avila Andrade, C. [11 ]
Sereno, M. [12 ]
Sanchez-Hernandez, A. [13 ]
Lopez-Brea, M. [14 ]
Massuti, B. [15 ]
Marti Blanco, C. [16 ]
Campayo, M. [17 ]
Arnaiz, P. [18 ]
Perez Parente, D. [18 ]
Fajardo, C. A. [18 ]
Ramos, I. [19 ]
机构：
[1] Hosp Gregorio Maranon, Madrid, Spain
[2] Catalan Inst Oncol ICO Badalona, Germans Trias & Pujol Res Inst IGTP, Dept Med Oncol, Badalona, Spain
[3] Badalona Appl Res Grp Oncol B ARGO, Germans Trias & Pujol Res Inst IGTP, Badalona, Spain
[4] Hosp Univ Nuestra Senora Candelaria, Santa Cruz De Tenerife, Spain
[5] Hosp San Pedro Alcantara, Caceres, Spain
[6] Hosp Arnau Vilanova, Lleida, Spain
[7] Hosp Univ Cent Asturias, Oviedo, Spain
[8] Hosp Clin San Carlos, Madrid, Spain
[9] Hosp Arnau Vilanova, Valencia, Spain
[10] Hosp Univ Reina Sofia, Cordoba, Spain
[11] Hosp Lluis Alcanyis Xativa, Valencia, Spain
[12] Hosp Infanta Sofia, Madrid, Spain
[13] Consorci Hosp Prov Castello, Castellon De La Plana, Spain
[14] Hosp Univ Marques Valdecilla, Santander, Spain
[15] Hosp Gen Alicante, Alicante, Spain
[16] Hosp Univ Sant Joan Reus, Reus, Spain
[17] Hosp Univ Mutua Terrassa, Terrassa, Spain
[18] Roche Farma SA, Madrid, Spain
[19] Hosp Univ Virgen Victoria, Malaga, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Real-World Data; NSCLC; atezolizumab;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP11.03-13
引用
收藏
页码：S625 / S626
页数：2
相关论文
共 50 条
  • [41] Real-world EGFR testing in patients with advanced EGFRm NSCLC in Belgium (REVEAL)
    Cuppens, K.
    Lodewyckx, L.
    Demedts, I.
    Decoster, L.
    Colinet, B.
    Deschepper, K.
    Janssens, A.
    Pauwels, P.
    Galdermans, D.
    Pieters, T.
    ANNALS OF ONCOLOGY, 2020, 31 : S1117 - S1117
  • [42] Outcomes of Anlotinib Maintenance Therapy in Patients With Advanced NSCLC in a Real-World Setting
    Li, Jia
    Han, Baohui
    Liu, Huaimin
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [43] Real-world EGFR testing patterns among US patients with advanced NSCLC
    Vanderpoel, Julie
    Pericone, Chris
    He, Jinghua
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (28)
  • [44] Survival of advanced melanoma patients treated with immunotherapy and targeted therapy: A real-world study
    Yu, Su-Yeon
    Mckavanagh, Dan
    McPherson, Ian
    Walpole, Euan
    Atkinson, Victoria
    Hollingworth, Samantha
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 (10) : 1371 - 1379
  • [45] Treatment Patterns and Outcomes of First-line Osimertinib-treated Advanced EGFR Mutated NSCLC Patients: A Real-world Study
    Lee, J. Y.
    Mai, V.
    Garcia, M.
    Cheng, S.
    Khan, K.
    Balaratnam, K.
    Thakral, A.
    Brown, M. C.
    Zhan, L.
    Corke, L.
    Leighl, N.
    Shepherd, F. A.
    Bradbury, P.
    Sacher, A.
    Liu, G.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S440 - S440
  • [46] Efficacy and Safety of Regorafenib Monotherapy among Patients with Previously Treated Metastatic Colorectal Cancer in a Chinese Population: A Real-World Exploratory Study
    Wang, Rui-Tao
    Zhao, Yang
    Wang, An-Lei
    Wang, Yu-Ting
    Yin, Zhong-Ping
    Chen, Kai
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 : 5363 - 5373
  • [47] Atezolizumab and bevacizumab in advanced hepatocellular carcinoma: Real-world data.
    Bezalel, Nomi
    Davidov, Yana
    Likhter, Mariya
    Ezra, Oranit Cohen
    Inbar, Yael
    Halpern, Naama
    Ben Boursi
    Beller, Tamar
    Pery, Ron
    Shmueli, Einat S.
    Nachmany, Ido
    Ben Ari, Ziv
    Margalit, Ofer
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [48] Real-world experience with atezolizumab (atezo) in advanced urothelial cancer (UC).
    Barata, Pedro C.
    Gopalakrishnan, Dharmesh
    Elson, Paul
    Koshkin, Vadim S.
    Ornstein, Moshe Chaim
    Diaz-Montero, C. Marcela
    Haywood, Samuel
    Rayman, Patricia A.
    Finke, James
    Lamenza, Marcelo
    Devonshire, Sarah
    Profusek, Pam
    Allman, Kimberly D.
    Martin, Allison
    Beach, Jennifer
    Schach, Kim
    Gilligan, Timothy D.
    Rini, Brian I.
    Garcia, Jorge A.
    Grivas, Petros
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [49] First-line osimertinib for patients with advanced NSCLC harboring EGFR mutations: A real-world study
    Ji, W.
    Jiang, D.
    Zhang, J.
    Zhang, H.
    Wang, Q.
    Cang, S.
    Li, X.
    Tan, J.
    Xiang, Y.
    Li, X.
    Liu, A.
    Lu, S.
    ANNALS OF ONCOLOGY, 2023, 34 : S1693 - S1693
  • [50] The real-world experience with nivolumab in previously treated patients with advanced non small cell lung cancer (NSCLC): A Galician Lung Cancer Group clinical practice.
    Areses, M. C.
    Campelo, Rosario Garcia
    Gonzalez, Jorge Garcia
    Afonso, Francisco Javier
    Lazaro, Martin Emilio
    Campos, Begona
    Azpitarte, Cristina
    Amenedo, Margarita
    Santome, Lucia
    Ron, David Arias
    Alonso-Jaudenes, Guillermo
    Baron, Francisco
    Vilchez, Rocio
    Casal, Joaquin
    Fernandez, Natalia
    Carou, Iria
    Mosquera, Joaquin
    Anido, Urbana
    Mata, Jesus Garcia
    Firvida, Jose-Iuis
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345